I remember a patient, let’s call her Sarah. She dragged herself into the clinic one afternoon, looking utterly drained. #BMP #calcium #CMP #dehydration #electrolyteimbalance #electrolytes #magnesium #potassium #Sodium
https://priya.health/this-phosphorus-based-molecule-helps-move-things-in-and-out-of-your-ce/
Baseline electrolyte disorders predict disease severity and mortality in patients with COVID-19
An observational study
Clinicians should closely follow up or reevaluate COVID-19 patients with baseline electrolyte disorders.
Our study demonstrates that hypocalcemia and hyponatremia at hospital admission effectively predict disease progression toward hospitalization and 30-day mortality in patients with COVID-19.
hospital admission predict severe disease and mortality in patients with coronavirus disease 2019 (COVID-19). We retrospectively collected data on the blood electrolyte concentrations of 286 COVID-19 patients at admission. The correlations between electrolyte imbalances, inflammation, and thrombosis markers in COVID-19 patients were also evaluated. We assessed the predictive performance of baseline blood electrolyte concentrations for severe disease and death using receiver operating characteristic curve analysis and multivariate logistic regression methods. Abnormalities in serum sodium, calcium, and potassium levels at admission were found at 20.6%, 14%, and 4.2%, respectively in this study. In the receiver operating characteristic curve analyses, hypocalcemia and hyponatremia effectively predicted disease progression to hospitalization (area under the curve 0.82, P < .001 and 0.81, P < .001, respectively) and 30-day mortality (area under the curve 0.85, P < .001 and 0.91, P < .001, respectively). In the multivariate logistic regression analysis, baseline hypocalcemia was identified as an independent risk factor associated with the risk of hospitalization (β = 2.019, P = .01; odds ratio: 7.53). Baseline hypocalcemia and hyponatremia effectively predicted disease progression toward hospitalization and 30-day mortality in patients with COVID-19. Clinicians should closely follow up or reevaluate COVID-19 patients with baseline electrolyte disorders....
🔬 Unveiling the ICD-10 Code for Hypochloremia! 🔬
Attention, coding enthusiasts and healthcare professionals! Today, we're shining a spotlight on hypochloremia coding—a crucial aspect of capturing and classifying electrolyte imbalances accurately.
🌐 Read the full blog post here: https://www.icd10-coding.com/2023/05/icd-10-code-for-hypochloremia.html
#ICD10Coding #Hypochloremia #MedicalCoding #ElectrolyteImbalance #HealthcareDocumentation #AccurateCoding #HealthcareData #MedicalClassification #CodingExcellence
https://www.icd10-coding.com/2023/05/icd-10-code-for-hypochloremia.html
For anyone who, like me, is perennially electrolyte challenged, allow me to recommend Kinderlyte over Pedialyte because it
1) doesn't taste like dammit,
2) has a little more and potassium sodium in it,
3) is comparably priced,
4) has packaging that is far easier to open with weak and shaky hands and
5) actually does seem to work faster.
#ElectrolyteImbalance is often reported among #COVID19 patients, and #hyponatremia is associated with a bad prognosis.
A discussion of the benefit of correcting hyponatremia with administration of #HypertonicSolutions.
https://www.frontiersin.org/articles/10.3389/fmed.2022.917008/full
Coronavirus disease 2019 (COVID-19) features hyper-inflammation, cytokine storm, neutrophil function changes, and sodium chloride (NaCl) homeostasis disruption, while the treatment with NaCl hypertonic solutions (HS) controls electrolytic body homeostasis and cell functions. HS treatment is a simple, popular, economic, and feasible therapy to regulate leukocyte function with a robust anti-inflammatory effect in many inflammatory diseases. The purpose of this narrative review is to highlight the knowledge on the use of HS approaches against viral infection over the past years and to describe the mechanisms involved in the release of neutrophil extracellular traps (NETs) and production of cytokine in severe lung diseases, such as COVID-19. We reported the consequences of hyponatremia in COVID-19 patients, and the immunomodulatory effects of HS, either in vitro or in vivo. We also described the relationship between electrolyte disturbances and COVID-19 infection. Although there is still a lack of clinical trials, hypertonic NaCl solutions have marked effects on neutrophil function and NETs formation, emerging as a promising adjuvant therapy in COVID-19.
Dr Priya Sammani ( MBBS ,DFM )
Zoomers of the Sunshine Coast 🇨🇦
ICD 10 Coding
helplessduck
Tui22